Oncology

165 publications in "Oncology"

May-21

Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases

Cardiovascular Men's Health Oncology Pharmacoepidemiology

Read more

Mar-21

Reviewing the impact of 11 national Be Clear on Cancer public awareness campaigns, England, 2012 to 2016: A synthesis of published evaluation results

Oncology

Read more

Jan-21

Angiotensin converting enzyme inhibitors and the risk of hepatocellular cancer: a nested cohort analysis

Hepatology Oncology

Read more

Jan-21

Digoxin use is associated with pancreatic cancer risk but does not affect survival

Hepatology Oncology Pharmacoepidemiology

Read more

Nov-20

Low-dose aspirin and risk of gastric and oesophageal cancer: a population-based study in the United Kingdom using The Health Improvement Network

Gastroenterology Oncology Pharmacoepidemiology

Read more

Sep-20

Long-term trends in lung cancer incidence in UK non-smokers: a cohort study of 3.7 million people

Oncology Respiratory

Read more

Sep-20

Long-term trends in lung cancer incidence in non-smokers: a UK-based cohort study of 3.7 million people

Oncology Respiratory

Read more

Aug-20

Twenty-year sociodemographic trends in lung cancer in non-smokers: A UK-based cohort study of 3.7 million people

Demographics Oncology Respiratory

Read more

Jul-20

Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population-based nested case-control studies

Dermatology Oncology Pharmacoepidemiology

Read more

Jun-20

Be Clear on Cancer: Fourth national blood in pee campaign, 2018

Oncology

Read more

May-20

No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction

Gastroenterology Men's Health Oncology Pharmacoepidemiology

Read more

Mar-20

The use of electronic healthcare records for colorectal cancer screening referral decisions and risk prediction model development

Gastroenterology Oncology

Read more
Date Title Categories
May-21 Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases

Cardiovascular Men's Health Oncology Pharmacoepidemiology

Mar-21 Reviewing the impact of 11 national Be Clear on Cancer public awareness campaigns, England, 2012 to 2016: A synthesis of published evaluation results

Oncology

Jan-21 Angiotensin converting enzyme inhibitors and the risk of hepatocellular cancer: a nested cohort analysis

Hepatology Oncology

Jan-21 Digoxin use is associated with pancreatic cancer risk but does not affect survival

Hepatology Oncology Pharmacoepidemiology

Nov-20 Low-dose aspirin and risk of gastric and oesophageal cancer: a population-based study in the United Kingdom using The Health Improvement Network

Gastroenterology Oncology Pharmacoepidemiology

Sep-20 Long-term trends in lung cancer incidence in UK non-smokers: a cohort study of 3.7 million people

Oncology Respiratory

Sep-20 Long-term trends in lung cancer incidence in non-smokers: a UK-based cohort study of 3.7 million people

Oncology Respiratory

Aug-20 Twenty-year sociodemographic trends in lung cancer in non-smokers: A UK-based cohort study of 3.7 million people

Demographics Oncology Respiratory

Jul-20 Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population-based nested case-control studies

Dermatology Oncology Pharmacoepidemiology

Jun-20 Be Clear on Cancer: Fourth national blood in pee campaign, 2018

Oncology

May-20 No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction

Gastroenterology Men's Health Oncology Pharmacoepidemiology

Mar-20 The use of electronic healthcare records for colorectal cancer screening referral decisions and risk prediction model development

Gastroenterology Oncology

1 2 3 4 14